N-phenethyl-2-hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxamides as possible anti-viral agents

Authors

  • I. V. Ukrainets National University of Pharmacy, Ukraine https://orcid.org/0000-0002-7302-4922
  • K. A. Taran National University of Pharmacy, Ukraine
  • N. L. Bereznyakova National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/ophcj.14.789

Keywords:

amides, West Nile Virus, 2-hydroxy-4-oxo-4H-pyrido[1, 2-a]pyrimidines, antiviral activity

Abstract

Based on the preliminary calculated screening performed by the PASS programme the synthesis of the group of the corresponding N-phenethyl-2-hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxamides as potential antiviral agents has been carried out by the interaction of ethyl esters of 2-hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxylic acids with 2-arylethylamines in boiling ethanol. Their structure has been confirmed by the data of elemental analysis and NMR 1H spectroscopy. Of the Herpesviruses family such viruses as Herpes Simplex Viruses Type 1 and 2, Varicella-Zoster Virus, Epstein-Barr Virus, as well as Cytomegalovirus have been involved in the screening research. Influenza Virus was presented by two types: A (subtypes H1N1, H3N2, H5N1) and B. The group of viruses affecting different sections of the respiratory tract included Parainfluenza Virus, SARS Virus, Rhinovirus, Adenovirus and Respiratory Syncytial Virus. Besides, Measles Virus, Vaccinia Virus and related Cowpox Virus, Hepatitis B and C Viruses, as well as Venezuelan Equine Encephalitis Virus were involved. The group of viruses causing febrile states of varying severity in human was presented by Rift Valley Fever Virus, West Nile Virus, Yellow Fever Virus, Dengue Virus and Tacaribe Virus. According to the results of the tests performed N-(4-chlorophenethyl)- 2-hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxamide has been recommended for further research. Having a low cytotoxicity this compound revealed a high antiviral activity in relation to the West Nile fever virus agent.

Downloads

Download data is not yet available.

References

  1. Pauli G., Bauerfeind U., Blümel J., Burger R., Drosten C., Gröner A., Gürtler L., Heiden M., Hildebrandt M., Jansen B., Montag-Lessing T., Offergeld R., Seitz R., Schlenkrich U., Schottstedt V., Strobel J., Willkommen H. Transfusion medicine and hemotherapy, 2013, Vol. 40, No.4, pp.265-284.
  2. Mancini F., Toma L., Ciervo A., Di Luca M., Faggioni G., Lista F., Resta G. The new microbiologica, 2013, Vol. 36, No.4, pp.433-434.
  3. Morin C.W., Comrie A.C. Proceedings of the National Academy of Sciences of the United States of America, 2013, Vol. 110, No.39, pp.15620-15625.
  4. Chen C.C., Jenkins E., Epp T., Waldner C., Curry P.S., Soos C. International journal of environmental research and public health, 2013, Vol. 10, No.7, pp.3052-3071.
  5. Lim S.P., Shi P.Y. Viruses, 2013, Vol. 5, No.12, pp.2977-3006.
  6. Roehrig J.T. Viruses, 2013, Vol. 5, No.12, pp.3088-3108.
  7. Wilson C.A., Bale J.F. Current infectious disease reports, 2014, Vol. 16, No.3, p.391.
  8. Van Doorn H.R. Medicine (Abingdon), 2014, Vol. 42, No.1, pp.60-63.
  9. Donadieu E., Bahuon C., Lowenski S., Zientara S., Coulpier M., Lecollinet S. Viruses, Vol. 5, No.11, pp.2856-2880.
  10. Adis International Limited. Drugs in R&D, 2007, Vol. 8, No.2, pp.113-119.
  11. Abubakr M., Mandal S.C., Banerjee S. Natural product communications, 2013, Vol. 8, No.10, pp.1487-1492.
  12. Furuta Y., Gowen B.B., Takahashi K., Shiraki K., Smee D.F., Barnard D.L. Antiviral research, 2013, Vol. 100, No.2, pp.446-454.
  13. Dayan G.H., Pugachev K., Bevilacqua J., Lang J., Monath T.P. Viruses, 2013, Vol. 5, No.12, pp.3048-3070.
  14. Ishikawa T., Yamanaka A., Konishi E. Vaccine, 2014, Vol. 32, No.12, pp.1326-1337.
  15. PASS (Prediction of Activity Spectra for Substances), available at: http://www.pharmaexpert.ru/PASSOnline/
  16. Ukrainets I.V., Bereznyakova N.L., Tugaibei I.A. Chemistry of Heterocyclic Compounds, 2008, Vol. 44, No.1, pp.50-63.
  17. Bereznyakova N.L., Ukrainets I.V., Tugaibei I.A., Gorokhova O.V. Medychna khimiya – Medical Chemistry, 2009, Vol. 11, No.2, pp.57-60.
  18. Ukrainets I.V., Bereznyakova N.L., Petyunin G.P., Tugaibei I.A., Rybakov V.B., Chernyshev V.V., Turov A.V. Chemistry of Heterocyclic Compounds, 2007, Vol. 43, No.6, pp.729-739.

Downloads

Published

2014-06-10

How to Cite

(1)
Ukrainets, I. V.; Taran, K. A.; Bereznyakova, N. L. N-Phenethyl-2-Hydroxy-4-Oxo-4H-pyrido[1,2-a]pyrimidine-3-Carboxamides As Possible Anti-Viral Agents. J. Org. Pharm. Chem. 2014, 12, 65-69.

Issue

Vol. 12 No. 2(46) (2014)

Section

Original Researches

License

Copyright (c) 2014 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:

1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.

3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).